Abstract
This study identifies cancer-driving mutations in histones as sites of PARP1-mediated ADP-ribosylation in breast and ovarian cancers, providing a molecular pathway by which cancers may subvert the growth-regulating effects of PARP1.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have